UroGen Pharma Ltd.'s investment thesis hinges on FDA approval of UGN-102. Click here to read more on URGN stock and its ...

Satsuma, a unit of a Japanese drugmaker with U.S. headquarters in Durham, said its treatment, called Atzumi, received its new ...

The High Court here has allowed an application by former Bersatu Youth chief Adam Asmuni to submit new evidence in his appeal ...

Pfizer also plans to make a $100 million equity investment in the Chinese biotechnolgoy company after the transaction closes, ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

The initiatives reflect the latest measures from federal agencies to reduce and ultimately replace animal testing in drug development and ...

Despite recent challenges ranging from wildfires to economic uncertainty, Los Angeles remains a prime destination, not only ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

If the initiative proceeds as planned, it will mark a pivotal shift in the regulatory landscape, introducing both efficiencies and novel ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

Apellis Pharmaceuticals focuses on creating medicines targeting eye diseases and rare neurological diseases. Read why I rate ...

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.